If you are suffering from mild to moderate Cystic Fibrosis and are between ages 14-50, the ongoing S-1226 drug study may be right for you. Please see below what would make you a suitable participant. For more information on S-1226, click here.

You are eligible to participate in the S-1226 drug study if you:

  • Are between 14 and 50 years of age.
  • Have a confirmed diagnosis of Cystic Fibrosis by at least one of the following:
    • sweat chloride concentration over 60 mosm/L.
    • genotype analysis identifying two disease causing mutations.
  • Clinically stable:
    • no pulmonary exacerbation of CF for which the patient has been. hospitalized or received intravenous antibiotics for 4 weeks.
    • no change in frequency of airway clearance.
  • Have access to means of transportation to Foothills Health Campus. and/or Children’s Hospital, Calgary AB CANADA.

You are not eligible if you:

  • Are pregnant or of child-bearing age without contraception.
  • Are breastfeeding.
  • Have a history of anxiety and/or panic disorders.
  • Are unable to perform airway clearance test twice a day during the study.
  • Are unable to produce acceptable and reproducible pulmonary function studies.
  • Had Gross Hemoptysis in the last 4 weeks.
  • Had Pneumothorax in the last 4 weeks.
  • Has elevated PaCO2 in the last 6 months.